These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24652550)

  • 21. Evaluation of thoracic impedance trends for implant-based remote monitoring in heart failure patients - Results from the (J-)HomeCARE-II Study.
    Maier SKG; Paule S; Jung W; Koller M; Ventura R; Quesada A; Bordachar P; García-Fernández FJ; Schumacher B; Lobitz N; Takizawa K; Ando K; Adachi K; Shoda M
    J Electrocardiol; 2019; 53():100-108. PubMed ID: 30739055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term impact of intrathoracic impedance findings on survival and heart failure hospitalizations after cardiac resynchronization therapy in ICD Registry patients.
    Brown JR; Alonso A; Warman EN; Bilchick KC
    Europace; 2018 Jul; 20(7):1138-1145. PubMed ID: 29016777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization.
    Yu CM; Wang L; Chau E; Chan RH; Kong SL; Tang MO; Christensen J; Stadler RW; Lau CP
    Circulation; 2005 Aug; 112(6):841-8. PubMed ID: 16061743
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrathoracic impedance monitoring in patients with heart failure: correlation with dehydration and bleeding events.
    Asada K; Fujiu K; Imai Y; Kojima T; Sugiyama H; Suzuki T; Kinugawa K; Hirata Y; Nagai R
    Circ J; 2012; 76(11):2592-8. PubMed ID: 22813787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathoracic impedance and ultrasound lung comets in heart failure deterioration monitoring.
    Maines M; Catanzariti D; Angheben C; Valsecchi S; Comisso J; Vergara G
    Pacing Clin Electrophysiol; 2011 Aug; 34(8):968-74. PubMed ID: 21477028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of intrathoracic impedance and remote monitoring in patients with an implantable device after the 2011 great East Japan earthquake.
    Suzuki H; Yamada S; Kamiyama Y; Takeishi Y
    Int Heart J; 2014; 55(1):53-7. PubMed ID: 24463930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient variations of transthoracic impedance as a predictor of heart failure and death in patients with implanted defibrillators.
    Mitrani RD; Sager SJ; Moscucci M; Cogan J; Myerburg RJ
    Int J Cardiol; 2014 Aug; 175(3):473-7. PubMed ID: 25012496
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An improved algorithm calculated from intrathoracic impedance can precisely diagnose preclinical heart failure events: Sub-analysis of a multicenter MOMOTARO (Monitoring and Management of OptiVol Alert to Reduce Heart Failure Hospitalization) trial study.
    Miyoshi A; Nishii N; Kubo M; Okamoto Y; Fujii S; Watanabe A; Okawa K; Kawamoto K; Morita H; Ito H
    J Cardiol; 2017 Nov; 70(5):425-431. PubMed ID: 28673507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathoracic impedance to monitor heart failure status: a comparison of two methods in a chronic heart failure dog model.
    Ganion V; Rhodes M; Stadler RW
    Congest Heart Fail; 2005; 11(4):177-81, 211. PubMed ID: 16106118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Device monitoring of intrathoracic impedance: clinical observations from a patient registry.
    Andriulli J
    Am J Cardiol; 2007 May; 99(10A):23G-8G. PubMed ID: 17512419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
    Braunschweig F; Ford I; Conraads V; Cowie MR; Jondeau G; Kautzner J; Lunati M; Munoz Aguilera R; Man Yu C; Marijianowski M; Borggrefe M; van Veldhuisen DJ;
    Eur J Heart Fail; 2008 Sep; 10(9):907-16. PubMed ID: 18715826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical link between heart failure self-care and intrathoracic impedance.
    Rathman LD; Lee CS; Sarkar S; Small RS
    J Cardiovasc Nurs; 2011; 26(4):E20-6. PubMed ID: 21076309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fundamentals of intrathoracic impedance monitoring in heart failure.
    Wang L
    Am J Cardiol; 2007 May; 99(10A):3G-10G. PubMed ID: 17512421
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic power and healthcare resource consumption of a dedicated workflow algorithm designed to manage thoracic impedance alerts in heart failure patients by remote monitoring.
    Ricci RP; Morichelli L; Porfili A; Quarta L; Sassi A
    J Cardiovasc Med (Hagerstown); 2018 Mar; 19(3):105-112. PubMed ID: 29283915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monitoring intrathoracic impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure.
    Catanzariti D; Lunati M; Landolina M; Zanotto G; Lonardi G; Iacopino S; Oliva F; Perego GB; Varbaro A; Denaro A; Valsecchi S; Vergara G;
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):363-70. PubMed ID: 19272067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring of heart failure: comparison of left atrial pressure with intrathoracic impedance and natriuretic peptide measurements in an experimental model of ovine heart failure.
    Rademaker MT; Charles CJ; Melton IC; Richards AM; Frampton CM; Siou J; Qu F; Eigler NL; Gutfinger D; Troughton RW
    Clin Sci (Lond); 2011 Mar; 120(5):207-17. PubMed ID: 20846122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
    van Veldhuisen DJ; Braunschweig F; Conraads V; Ford I; Cowie MR; Jondeau G; Kautzner J; Aguilera RM; Lunati M; Yu CM; Gerritse B; Borggrefe M;
    Circulation; 2011 Oct; 124(16):1719-26. PubMed ID: 21931078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of All-Cause Mortality Based on the Direct Measurement of Intrathoracic Impedance.
    Zile MR; Sharma V; Johnson JW; Warman EN; Baicu CF; Bennett TD
    Circ Heart Fail; 2016 Jan; 9(1):e002543. PubMed ID: 26699393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.